LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE‐155 STUDY

Photo from wikipedia

Tucson, United States; Medical Oncologist, Virginia Cancer Specialists, US Oncology Research, Woodbridge, United States; Hematology, Fred Hutchinson Cancer Research Center, Seattle, United States; Medical Oncology & Hematology, Northwest Cancer Specialists,… Click to show full abstract

Tucson, United States; Medical Oncologist, Virginia Cancer Specialists, US Oncology Research, Woodbridge, United States; Hematology, Fred Hutchinson Cancer Research Center, Seattle, United States; Medical Oncology & Hematology, Northwest Cancer Specialists, US Oncology Research, Vancouver, United States; Division of Hematology and Oncology, Georgetown University Hospital, Washington, DC, United States; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States

Keywords: antitumor activity; hematology; cancer; lymphoma; united states; oncology

Journal Title: Hematological Oncology
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.